Table 1.
Domains | Components | Tools | Interpretation and/or Norm Values | Interventions |
---|---|---|---|---|
Functional Capacity | Exercise capacity | Muscle fatigue, Gait Speed, 6MWT | Gait speed > 0.8 m/s: 6MWT must re-performed in time (patient itself control) | Endurance and/or resistance training |
Muscle strenght | Handgrip | Handgrip (Fried’s criteria): Men ≥ 29–32 kgf and Women ≥ 17–21 kgf (adjusted for BMI) | Resistance training | |
Balance | Tinetti scale/SPPB | Fall risk is moderate to high if SPPB < 10 and Tinetti scale < 25 | Balance and coordination training | |
Sarcopenia | Gait speed/SPPB | Gait speed > 0.8 m/s, Handgrip (Fried’s criteria): Men ≥ 29–32 kgf and Women ≥ 17–21 kgf (adjusted for BMI), SPPB < 10 | Endurance walking exercise | |
Energy expenditure | MLTAQ-short version | Kcal/week expended: Men < 383 Women < 270 | Reduce sedentary time and increase daily-life activity | |
Dependency | ADL/IADL | Reach independence: ≥4/6 items, ≥6/8 items | Provide functional exercises relevant to daily life | |
Comorbidity | Number and severity of chronic conditions | Medical record analysis, CIRS | Check for major (chronic) conditions | Tailor intervention based on medical history |
Bleeding risk | HAS-BLED, PRECISE-DAPT score | HAS-BLED 5–8 High risk; PRECISE-DAPT score ≥ 25 Short DAPT | Optimize therapy: Standard/long DAPT (12–24 months), short DAPT (3–6 months) | |
Polypharmacy | Teraphy check | Number/ indication of single drug | Avoid adverse combinations and/or reduce unnecessary medications | |
Anemia | Laboratory testing | Serum Hemoglobin level: Men >13 g/dL Women >12 g/dL (check MCV, iron blood levels, serum ferritin, TIBC, Vitamin B12, folate) | Consider iron prescription/erythropoetin | |
Albuminemia | Laboratory testing | Serum Albumin 3.5–4.5 mg/dL | Nutritional counseling | |
Diabetes | Laboratory testing and clinical examination | Fasting plasma glucose >100 mg/dL and HbA1c <6.0%; Check diabetes neuropathy, retinopathy | Elevate physical activity, health nutrition with weight loss and/or prescription of metformin | |
Dyslipidemia | Laboratory testing | Total Cholesterol, LDL cholesterol, TG, norm value dependent on CV risk | Elevate physical activity, health nutrition with weight loss and/or prescription of statin | |
Thyroid dysfunction | Laboratory testing | TSH, FT3, FT4: normal value dependent on age and sex | Check periodically | |
Renal dysfunction | Laboratory testing | Blood Urea Nitrogen, Creatinine, eGFR, normal value dependent on age and sex | Check periodically | |
Liver dysfunction | Laboratory testing | AST, ALT, GGT, normal value dependent on age and sex | Check periodically | |
Hypovitaminosis | Laboratory testing | 25-OH-vitaminD (>30 ng/mL) | Consider prescription of 25-OH-vitaminD or Calcifediol | |
Disturbed blood pressure | BP assessment | Systolic blood pressure target in elderly no lower than 130 mmHg | Consider pharmacotherapy in case of hypotension or hypertension | |
Hearing loss | Audiometry | Impaired hearing function, especially conversational frequencies | Consider hearing aids | |
Pulmonary dysfunction | Spirometry | Check FEV and Tiffenau index | Consider specialist counseling | |
Cardiac dysfunction | Ecocardiography/Laboratory testing | Ejection fraction % ≥ 55, E/A ratio ≥ 1, NT-proBNP < 450 pg/mL (in 75–99 years) | Optimize therapy | |
Nutritional status | Calories intake | MNA | Check for adequate calorie intake | Promote sufficient calories intake |
Protein intake | NRS 2002 | Check for adequate protein intake: in elderly around 1–1.2 g/kg/day | Promote healthy protein-rich food items | |
Loss of appetite | Self-reported unexplained weight loss | More than 4.5 kg or 5% of body weight in past year | Promote sufficient calories and protein intake | |
Water intake | Dehydratation | Check for water intake | Promote water intake adequate on singular needing | |
Cognitive Function | Memory and executive functions | MMSE | Detect Mild Cognitive Impairment (MCI): MMSE < 26 points (age and scholar correction) | Consider specific diagnostic study |
Physicological function | Mood | GDS | Check for mood disorders if GDS < 10 points | Consider specific diagnostic study |
Cognition | MINI-Cog test | Score ≥ 3 indicate lower likelihood of dementia | Consider specific diagnostic study | |
Social Support | Family or community support | Caregiver presence | Check for family support | Help organising faimily support |
Financial resources | Check for financial issues/constraints | Refer to social worker if needed | ||
Smoking behaviour | Anamnesis | Avoid active and passive smoking | Quit smoking and/or avoid smoking exposure |
Captions: 6MWT, 6 min walking test; ADL/IADL, Activities of daily living/Instrumental activities of daily living; AST, Aspartate Aminotransferase; ALT, Alanine Aminotransferase; BMI, Body mass index; BP, Blood Pressure; CIRS, Cumulative Illness Rating Scale; CPET, Cardiopulmonary exercise test; CV risk, Cardiovascular risk; DAPT, Dual Antiplatelet Therapy; eGFR, Estimated glomerular filtration rate; FEV, Forced Expiratory Volume; GGT, Gamma-Glutamyl Transferase; GDS, Geriatric depression scale; HASBLED score, Hypertension, Abnormal renal/liver function, Stroke, Bleeding history, Labile International Normalized Ratio or INR, Elderly >65 years, Drugs/alcohol concomitantly; HbA1c, Glycated Hemoglobin; LDL cholesterol, Low Density Lipoprotein; MCV, Mean Corpuscular volume; MLTAQ-short version, Minnesota Leisure Time Activity Questionnaire; MMSE, Mini mental state examination; MNA, Mini nutritional assessment; NRS 2002, Nutritional risk screening; NT-pro-BNP, N terminal pro-brain natriuretic peptide; PRECISE-DAPT, PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent DAPT; SPPB, Short physical performance battery; TG, Triglycerides; TIBC, total iron binding capacity; FT3, Free Triiodothyronine; FT4, Free Thyroxine; TSH, Thyroid-stimulating hormone.